PerkinElmer

FEBRUARY 18, 2021

Industry leaders reveal how high throughput screening is changing in R&D What do you think are the major trends in drug discovery R&D? That is not what PerkinElmer found in a comprehensive survey of leaders at the top 20 Pharma, ranked for R&D spending. A PerkinElmer White Paper offers a detailed look at the findings.

Biochemical Assays 52

Biochemical Assays Drugs Small Molecule Pharma Companies 52

The Pharma Data

NOVEMBER 20, 2020

According to a benchmarking survey by TraceLink , 532 global supply chain leaders from various leading pharma companies, wholesale distributors, hospitals and pharmacies have indicated the supply chain has been severely impacted by the Covid-19 pandemic. Save your early bird seat now.

Pharma Companies 52

Pharma Companies Vaccine Pharmacy Drugs 52

H1 Blog

NOVEMBER 15, 2023

Anti-kickback laws are federal statutes designed to protect patients from paying more than necessary for medical services or devices by preventing physicians from receiving kickbacks or bribes in exchange for referring patients to certain providers or prescribing certain drugs.

Compliance 59

Compliance Science Regulations Pharmaceutical Companies 59

Drug Discovery World

SEPTEMBER 29, 2022

Challenges in outsourcing drug discovery. The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time. Many companies have several projects ongoing simultaneously, which can limit internal resources (space, lab equipment, personnel) and delay progress.

Small Molecule 130

Small Molecule Assay Development DNA Biochemical Assays 130

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. acting, water-soluble version of remdesivir.

Clinical Trials 52

Clinical Trials Pharma Companies Hospitals Trials 52

The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. Download Medidata’s white paper to learn how to virtualize clinical trials and bring new therapies closer to patients.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Clinical Research 52